Luye Pharma Group Ltd
HKEX:2186

Watchlist Manager
Luye Pharma Group Ltd Logo
Luye Pharma Group Ltd
HKEX:2186
Watchlist
Price: 3.01 HKD 1.69% Market Closed
Market Cap: 12B HKD

Intrinsic Value

The intrinsic value of one Luye Pharma Group Ltd stock under the Base Case scenario is 5.26 HKD. Compared to the current market price of 3.01 HKD, Luye Pharma Group Ltd is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
5.26 HKD
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Luye Pharma Group Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Luye Pharma Group Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Luye Pharma Group Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Luye Pharma Group Ltd.

Explain Valuation
Compare Luye Pharma Group Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Luye Pharma Group Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Luye Pharma Group Ltd

Current Assets 15.7B
Cash & Short-Term Investments 8.8B
Receivables 3.5B
Other Current Assets 3.3B
Non-Current Assets 16.3B
Long-Term Investments 2.5B
PP&E 5.9B
Intangibles 7.8B
Other Non-Current Assets 111.7m
Efficiency

Free Cash Flow Analysis
Luye Pharma Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Luye Pharma Group Ltd

Revenue
6.2B CNY
Cost of Revenue
-2B CNY
Gross Profit
4.1B CNY
Operating Expenses
-2.7B CNY
Operating Income
1.4B CNY
Other Expenses
-1B CNY
Net Income
396.9m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Luye Pharma Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Healthy Operating Margin
51/100
Profitability
Score

Luye Pharma Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Luye Pharma Group Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
42/100
Solvency
Score

Luye Pharma Group Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Luye Pharma Group Ltd

Wall Street analysts forecast Luye Pharma Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Luye Pharma Group Ltd is 4.44 HKD with a low forecast of 3.74 HKD and a high forecast of 5.25 HKD.

Lowest
Price Target
3.74 HKD
24% Upside
Average
Price Target
4.44 HKD
47% Upside
Highest
Price Target
5.25 HKD
74% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Luye Pharma Group Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Luye Pharma Group Ltd stock?

The intrinsic value of one Luye Pharma Group Ltd stock under the Base Case scenario is 5.26 HKD.

Is Luye Pharma Group Ltd stock undervalued or overvalued?

Compared to the current market price of 3.01 HKD, Luye Pharma Group Ltd is Undervalued by 43%.

Back to Top